Regenta is a Chinese business development advisory firm serving companies in the life sciences industry.

We focus on licensing and financing and work with leading life sciences companies in the United States, Europe, and Asia. Regenta’s industry experts have deep scientific and clinical knowledge and a broad spectrum of practices ranging from discovery research, product development, product marketing and regulatory affairs and IP to creative transactional experience. Our partners are senior industry executives with extensive experience and networks and have a good understanding of the challenges our clients face when entering into China and the rest of Asia.

Regenta aims at developing a market entry model that fits the clients best and implementing it seamlessly for the clients. We are a partner of choice for companies seeking knowledgeable advice on pharmaceutical asset sale, and licensing transactions.